Abstract:Background: Poly(trimethylene carbonate) (PTMC) has wide biomedical applications in the field of tissue engineering, due to its biocompatibility and biodegradability features. Its common manufacturing involves photofabrication, such as stereolithography (SLA), which allows the fabrication of complex and controlled structures. Despite the great potential of SLA-fabricated scaffolds, very few examples of PTMC-based drug delivery systems fabricated using photo-fabrication can be found ascribed to light-triggered therapeutics instability, degradation, side reaction, binding to the macromers, etc. These concerns severely restrict the development of SLA-fabricated PTMC structures for drug delivery purposes. Methods: In this context, we propose here, as a proof of concept, to load a drug model (dexamethasone) into electrospun fibers of poly(lactic acid), and then to integrate these bioactive fibers into the photo-crosslinkable resin of PTMC to produce hybrid films. The hybrid films' properties and drug release profile were characterized; its biological activity was investigated via bone marrow mesenchymal stem cells culture and differentiation assays. Results: The polymer/polymer hybrids exhibit improved properties compared with PTMC-only films, in terms of mechanical performance and drug protection from UV denaturation. We further validated that the dexamethasone preserved its biological activity even after photoreaction within the PTMC/poly(lactic acid) hybrid structures by investigating bone marrow mesenchymal stem cells proliferation and osteogenic differentiation. Conclusion: This study demonstrates the potential of polymer-polymer scaffolds to simultaneously reinforce the mechanical properties of soft matrices and to load sensitive drugs in scaffolds that can be fabricated via additive manufacturing.

Controlled Bioactive Delivery Using Degradable Electroactive Polymers

Development of Random and Ordered Composite Fiber Hybrid Technologies for Controlled Release Functions

Biodegradable electroactive polymers for electrochemically-triggered drug delivery.

Functional poly(dimethyl aminoethyl methacrylate) by combination of radical ring-opening polymerization and click chemistry for biomedical applications

Self-powered, Light-Controlled, Bioresorbable Platforms for Programmed Drug Delivery

Electroactive Polymers for On-Demand Drug Release

Modulating Drug Release from Short Poly(ethylene Glycol) Block Initiated Poly(L-lactide) Di-block Copolymers

Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses

A drug eluting poly(trimethylene carbonate)/poly(lactic acid)-reinforced nanocomposite for the functional delivery of osteogenic molecules

Electro-responsive controlled drug delivery from melanin nanoparticles

Controlled Release of Dexamethasone from Porous PLGA Scaffolds under Cyclic Loading

Poly(lactic acid) Controlled Drug Delivery

Electrospun fibers of acid-labile biodegradable polymers with acetal groups as potential drug carriers.

Photochemically Controlled Drug Dosing from a Polymeric Scaffold

Polyterthiophene as an electrostimulated controlled drug release material of therapeutic levels of dexamethasone

Polymeric Composite Matrix with High Biobased Content As Pharmaceutically Relevant Molecular Encapsulation and Release Platform.

Drug delivery via a 3D electro-swellable conjugated polymer hydrogel

Electroresponsive and Cell-Affinitive Polydopamine/polypyrrole Composite Microcapsules with a Dual-Function of On-Demand Drug Delivery and Cell Stimulation for Electrical Therapy

Design of Controlled Drug Delivery System with Optimal Release Characteristics

Biodegradable and Electrically Conducting Polymers for Biomedical Applications

Zwitterionic Strategy to Stabilize Self‐immolative Polymer Nanoarchitecture Under Physiological pH for Drug Delivery In vitro and In vivo